We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.38B
AUM Growth
+$250M
Cap. Flow
-$95M
Cap. Flow %
-1.49%
Top 10 Hldgs %
24.3%
Holding
176
New
25
Increased
62
Reduced
40
Closed
19

Top Buys

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$45.6M
2
ROL icon
Rollins
ROL
+$37.7M
3
CPRT icon
Copart
CPRT
+$36.7M
4
MDB icon
MongoDB
MDB
+$36.7M
5
TTD icon
Trade Desk
TTD
+$36.6M

Sector Composition

Rank Sector Weight
1 Healthcare 38.57%
2 Technology 24.76%
3 Industrials 16.51%
4 Consumer Discretionary 8.57%
5 Communication Services 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AURA icon
51
Aura Biosciences
AURA
$735M
$45.6M 0.71%
5,802,682
KROS icon
52
Keros Therapeutics
KROS
$202M
$45M 0.71%
680,000
+100,000
+17% +$5.93M
PCVX icon
53
Vaxcyte
PCVX
$8.08B
$44.9M 0.7%
657,206
+50,000
+8% +$3.46M
MSCI icon
54
MSCI
MSCI
$41.9B
$44.4M 0.7%
79,209
+50,185
+173% +$28.2M
FIVN icon
55
FIVE9
FIVN
$2.12B
$43.8M 0.69%
705,290
+1,739
+0.2% +$121K
LSCC icon
56
Lattice Semiconductor
LSCC
$17.7B
$43.5M 0.68%
556,672
+1,343
+0.2% +$96.1K
FERG icon
57
Ferguson
FERG
$43.9B
$42.1M 0.66%
192,548
+22,186
+13% +$4.42M
CPRT icon
58
Copart
CPRT
$27.4B
$41.3M 0.65%
+713,209
New +$36.7M
GTLB icon
59
GitLab
GTLB
$5.7B
$40.6M 0.64%
+695,704
New +$45.6M
SNPS icon
60
Synopsys
SNPS
$71.3B
$40.1M 0.63%
70,238
+13,906
+25% +$7.65M
AJG icon
61
Arthur J. Gallagher & Co
AJG
$65.9B
$39M 0.61%
156,160
+29,974
+24% +$7.21M
DVAX
62
DELISTED
Dynavax Technologies
DVAX
$36M 0.56%
2,896,953
+3,518
+0.1% +$45.9K
ORLY icon
63
O'Reilly Automotive
ORLY
$72.4B
$35.9M 0.56%
476,520
+9,915
+2% +$693K
VRNA
64
DELISTED
Verona Pharma
VRNA
$35.2M 0.55%
2,187,520
+809,739
+59% +$14M
ALV icon
65
Autoliv
ALV
$9.09B
$34.1M 0.53%
283,193
+89,287
+46% +$9.99M
SHW icon
66
Sherwin-Williams
SHW
$83.7B
$33M 0.52%
94,966
+644
+0.7% +$205K
CELC icon
67
Celcuity
CELC
$4.27B
$30M 0.47%
+1,390,000
New +$22.2M
ISRG icon
68
Intuitive Surgical
ISRG
$126B
$30M 0.47%
75,225
-1,469
-2% -$555K
HLI icon
69
Houlihan Lokey
HLI
$8.97B
$29.4M 0.46%
229,183
+53,914
+31% +$6.67M
IRTC icon
70
iRhythm Holdings
IRTC
$3.91B
$27.7M 0.44%
239,135
AXSM icon
71
Axsome Therapeutics
AXSM
$12.1B
$27.7M 0.43%
346,712
WMB icon
72
Williams Companies
WMB
$86.7B
$27.6M 0.43%
707,120
-89,293
-11% -$3.17M
PNR icon
73
Pentair
PNR
$10.6B
$27.1M 0.42%
316,798
-37,343
-11% -$2.83M
EGP icon
74
EastGroup Properties
EGP
$11.3B
$27M 0.42%
150,452
+12,422
+9% +$2.24M
SRRK icon
75
Scholar Rock
SRRK
$5.87B
$26.9M 0.42%
1,513,280
+540,547
+56% +$8.51M

Similar funds

Eventide Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Eventide Asset Management held 176 positions worth $6.38B, up 4.1% from $6.13B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q1 2024 filing shows 25 new, 62 increased, 40 reduced and 19 closed positions. Its largest new stake was GitLab: 695,704 shares worth $40.6M. The largest sale was CrowdStrike, an estimated $76.4M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2024 buy was GitLab: 695,704 shares worth $40.6M.
  • Eventide Asset Management added most to Rollins in Q1 2024, an estimated $37.7M increase.
  • Eventide Asset Management's biggest Q1 2024 reduction was CrowdStrike, cutting an estimated $76.4M.
  • Eventide Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $60.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.38B portfolio in Q1 2024.
  • Eventide Asset Management opened 25 new positions and closed 19 in Q1 2024.
  • Eventide Asset Management's portfolio value rose 4.1% quarter-over-quarter to $6.38B.

Based on Eventide Asset Management's 13F filing for Q1 2024, filed 15 May 2024.